Cellular Dynamics International Receives $21,041,664 New Funding

  • Feed Type
  • Date
    11/6/2012
  • Company Name
    Cellular Dynamics International
  • Mailing Address
    525 Science Drive Madison, WI 53711
  • Company Description
    Cellular Dynamics (NASDAQ: ICEL) was founded by three world-class scientists in cardiac ion channel models, hES cells, and iPS cells to provide cardiac toxicity drug testing services, including GLP and non-GLP hERG electrophysiological assays as well as action potential and cytotoxicity screens using hES-cell derived cardiomycytes.
  • Website
    http://www.cellulardynamics.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $21,041,664
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed